The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies

Overview of attention for article published in Respiratory Research, May 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 39 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Casgo Connections, 23 May 2016

Reducing the severity of respiratory symptoms is a key goal in the treatment of chronic obstructive pulmonary disease (COPD).

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.